Shares of Amrize Ltd (NYSE:AMRZ – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seventeen research firms that are covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $64.0714.
A number of analysts recently issued reports on AMRZ shares. Oppenheimer reissued an “outperform” rating and set a $70.00 target price (up from $64.00) on shares of Amrize in a research note on Thursday, February 19th. Wells Fargo & Company lowered their target price on Amrize from $66.00 to $65.00 and set an “overweight” rating for the company in a research note on Wednesday, April 15th. Truist Financial increased their target price on Amrize from $60.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. Bank of America set a $58.00 target price on Amrize in a research note on Monday, January 12th. Finally, Citigroup raised their price target on shares of Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th.
Check Out Our Latest Stock Analysis on AMRZ
Insider Activity at Amrize
Hedge Funds Weigh In On Amrize
Several hedge funds have recently made changes to their positions in AMRZ. Geode Capital Management LLC bought a new position in shares of Amrize during the 2nd quarter worth approximately $265,000. M&T Bank Corp bought a new position in shares of Amrize during the 2nd quarter worth approximately $205,000. Arrowstreet Capital Limited Partnership bought a new position in shares of Amrize during the 2nd quarter worth approximately $3,870,000. Gabelli Funds LLC bought a new position in shares of Amrize in the second quarter valued at $1,083,000. Finally, AXA S.A. bought a new position in shares of Amrize in the second quarter valued at $1,065,000.
Amrize Price Performance
NYSE AMRZ opened at $58.10 on Friday. The business has a 50 day simple moving average of $58.20 and a 200 day simple moving average of $54.79. Amrize has a 52-week low of $44.12 and a 52-week high of $65.94. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64. The stock has a market cap of $32.13 billion and a price-to-earnings ratio of 23.62.
Amrize (NYSE:AMRZ – Get Free Report) last posted its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The business had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.95 billion. Amrize’s revenue for the quarter was down .4% on a year-over-year basis. Analysts anticipate that Amrize will post 2.76 earnings per share for the current fiscal year.
Amrize Announces Dividend
The firm also recently declared a dividend, which will be paid on Monday, May 4th. Stockholders of record on Monday, April 27th will be paid a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, April 24th.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Stories
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
